Can we predict the prognosis of COPD with a routine blood test?
- PMID: 28243079
- PMCID: PMC5315204
- DOI: 10.2147/COPD.S124041
Can we predict the prognosis of COPD with a routine blood test?
Abstract
Background: The major characteristic of COPD is systemic inflammation. The parameters such as neutrophil-to-lymphocyte ratio (NLR) and eosinophil-to-basophil ratio (EBR) in routine blood test (RBT) are considered to be the underlying biomarkers of inflammation. We hypothesized that the prognosis of patients with COPD can be predicted with RBT.
Methods: Patients with COPD in stable stage were enrolled. The RBT, pulmonary function testing (PFT), BODE index, C-reactive protein (CRP), procalcitonin, and erythrocyte sedimentation rate (ESR) were performed at enrollment and every follow-up once in every 3 months during the 24-month follow-up period. Meanwhile, exacerbation count and mortality incidence were recorded. The correlation between the prognostic biomarkers and the prognosis of patients was analyzed.
Results: The NLR and EBR in RBT have a significant correlation with the severity of patients with COPD. The NLR is an independent predictor for mortality and the EBR is an independent predictor for exacerbation.
Conclusion: As an inexpensive, accessible, and convenient assay, RBT may be used as a practical means in the prediction of prognosis of patients with COPD in future clinical settings.
Keywords: COPD; eosinophil-to-basophil ratio; inflammation; neutrophil-to-lymphocyte ratio; prognosis; routine blood test.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.Clin Respir J. 2017 May;11(3):311-317. doi: 10.1111/crj.12336. Epub 2015 Aug 6. Clin Respir J. 2017. PMID: 26096858
-
The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.Panminerva Med. 2017 Sep;59(3):203-209. doi: 10.23736/S0031-0808.17.03296-7. Epub 2017 Feb 9. Panminerva Med. 2017. PMID: 28185443
-
Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.Int J Chron Obstruct Pulmon Dis. 2018 Nov 5;13:3651-3662. doi: 10.2147/COPD.S178068. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30464448 Free PMC article.
-
The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.Int J Chron Obstruct Pulmon Dis. 2015 Nov 11;10:2469-78. doi: 10.2147/COPD.S90330. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26648709 Free PMC article.
-
Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients.Expert Rev Respir Med. 2020 Jan;14(1):111-116. doi: 10.1080/17476348.2019.1675517. Epub 2019 Oct 13. Expert Rev Respir Med. 2020. PMID: 31577911 Review.
Cited by
-
Effects of complications associated with chronic obstructive pulmonary disease on lung function and hospitalization expenses: A retrospective study.Medicine (Baltimore). 2025 May 2;104(18):e42274. doi: 10.1097/MD.0000000000042274. Medicine (Baltimore). 2025. PMID: 40324270 Free PMC article.
-
Catching "Early" COPD - The Diagnostic Conundrum.Int J Chron Obstruct Pulmon Dis. 2021 Apr 13;16:957-968. doi: 10.2147/COPD.S296842. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33880020 Free PMC article. Review.
-
Using inflammatory index to distinguish asthma, asthma-COPD overlap and COPD: A retrospective observational study.Front Med (Lausanne). 2022 Nov 17;9:1045503. doi: 10.3389/fmed.2022.1045503. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36465915 Free PMC article.
-
Hematological Parameters for Predicting Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.J Clin Med. 2023 Jun 23;12(13):4227. doi: 10.3390/jcm12134227. J Clin Med. 2023. PMID: 37445262 Free PMC article.
-
Prognostic value of composite inflammatory markers in patients with chronic obstructive pulmonary disease: A retrospective cohort study based on the MIMIC-IV database.PLoS One. 2025 Jan 24;20(1):e0316390. doi: 10.1371/journal.pone.0316390. eCollection 2025. PLoS One. 2025. PMID: 39854548 Free PMC article.
References
-
- Wain LV, Shrine N, Miller S, et al. UK Brain Expression Consortium (UKBEC) OxGSK Consortium Novel insights into the genetics of smoking behavior, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir Med. 2015;3(10):769–781. - PMC - PubMed
-
- Vogelmeier C, Hederer B, Glaab T, et al. POET-COPD Investigators Tiotropium versus Salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011;364(12):1093–1103. - PubMed
-
- Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005;352(19):1967–1976. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous